We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Schering-Plough Corp. | NYSE:SGP | NYSE | Ordinary Share |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 28.15 | 0.00 | 00:00:00 |
From Jan 2020 to Jan 2025
The European Commission Friday cleared pharmaceuticals company Merck & Co. (MRK) to buy Schering-Plough Corp. (SGP).
Merck is paying $41.1 billion in cash and stock for Schering.
To avoid antitrust problems, Merck has sold its 50% stake in animal-health company Merial Limited to Sanofi-Aventis SA (SNY), its partner in the joint venture.
-By Adam Cohen, Dow Jones Newswires; +322 741 1486; adam.cohen@dowjones.com
1 Year Schering Plough Chart |
1 Month Schering Plough Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
